This project presents a mathematical model of the biochemical pathways involved in remyelination during multiple sclerosis. The model examines several major factors involved in remyelination and their expression over a course of time. This model also highlights processes which are targets for pharmaceutical treatment improving remyelination. The treatments examined include current treatments, drugs being examined for clinical trial, and theoretical treatments. Construction of the model is rooted in Biochemical Systems Theory (BST), which has been successfully applied in the past to examine the biochemistry of neurodegenerative disease. The model uses MATLAB as a means of coding the biochemical pathways into a system of ordinary differential...
AbstractMyelin is critical in maintaining electrical impulse conduction in the central nervous syste...
Remyelination therapies, which are currently under development, have a great potential to delay, pre...
Despite intense research, few treatments are available for most neurological disorders. Demyelinatin...
Demyelinating diseases of the central nervous system (CNS), such as multiple sclerosis (MS), are cha...
Regenerative medicines that promote remyelination in multiple sclerosis (MS) are making the transiti...
Multiple Sclerosis (MS) is an inflammatory disease which causes areas of demyelination in the Centr...
Remyelination involves reinvesting demyelinated axons with new myelin sheaths. In stark contrast to ...
AbstractMyelin, a dielectric sheath that wraps large axons in the central and peripheral nervous sys...
Remyelination in the CNS is the natural process of damage repair in demyelinating diseases such as m...
The authors acknowledge the following support: The UK Multiple Sclerosis Society (MS50 to R.T.K., C....
Multiple sclerosis is a complex and heterogeneous immune-mediated disease that results in the progre...
Abstract: The greatest unmet need in multiple sclerosis (MS) are treatments that delay, prevent or r...
Remyelination, the ability of oligodendrocytes to extend myelin sheaths to wrap demyelinated axons, ...
Amongst neurological diseases, multiple sclerosis (MS) presents an attractive target for regenerativ...
Multiple sclerosis (MS) is a progressive neurodegenerative disorder which occurs when autoreactive T...
AbstractMyelin is critical in maintaining electrical impulse conduction in the central nervous syste...
Remyelination therapies, which are currently under development, have a great potential to delay, pre...
Despite intense research, few treatments are available for most neurological disorders. Demyelinatin...
Demyelinating diseases of the central nervous system (CNS), such as multiple sclerosis (MS), are cha...
Regenerative medicines that promote remyelination in multiple sclerosis (MS) are making the transiti...
Multiple Sclerosis (MS) is an inflammatory disease which causes areas of demyelination in the Centr...
Remyelination involves reinvesting demyelinated axons with new myelin sheaths. In stark contrast to ...
AbstractMyelin, a dielectric sheath that wraps large axons in the central and peripheral nervous sys...
Remyelination in the CNS is the natural process of damage repair in demyelinating diseases such as m...
The authors acknowledge the following support: The UK Multiple Sclerosis Society (MS50 to R.T.K., C....
Multiple sclerosis is a complex and heterogeneous immune-mediated disease that results in the progre...
Abstract: The greatest unmet need in multiple sclerosis (MS) are treatments that delay, prevent or r...
Remyelination, the ability of oligodendrocytes to extend myelin sheaths to wrap demyelinated axons, ...
Amongst neurological diseases, multiple sclerosis (MS) presents an attractive target for regenerativ...
Multiple sclerosis (MS) is a progressive neurodegenerative disorder which occurs when autoreactive T...
AbstractMyelin is critical in maintaining electrical impulse conduction in the central nervous syste...
Remyelination therapies, which are currently under development, have a great potential to delay, pre...
Despite intense research, few treatments are available for most neurological disorders. Demyelinatin...